 |
Regenera Appoints Dr. Deupree As Investigator
For immediate release
Perth, August 27:
Regenera today announced
that it has appointed two distinguished U.S.
ophthalmologists to its clinical and medical
advisory board.
 Dr. Dana Deupree of The
Macula Center, Palm Harbor, Florida, and Dr. David
Boyer, Dr. Gholam Peyman and Dr. Don Sanders will be joining the team to assist in the
investigation of VisagenTM
as a treatment to improve the effectiveness of the
surgical procedure called
vitrectomy.
Vitrectomy is a common form of eye surgery, often
required as a result of
diabetes-related eye diseases or other disorders
that affect the
retina and other sensitive areas at the back of
the eye. Vitrectomy involves the removal of the
vitreous (gel like substance) from the centre of
the eye so that a surgeon can identify and remove
loose blood particles and scar tissue that obscure
the patient’s vision.
Over 150,000 vitrectomy operations are performed
each year in the U.S. alone reflecting a sizeable
potential market for VisagenTM.
Regenera’s lead product, VisagenTM,
will be tested for use by Dr. Deupree to enhance his
ability to visualise and clarify the vitreous fluid.
This is a necessary step in the surgery as all of
the fluid and loose particles must be removed to
ensure the highest likelihood that the patient
regains full vision.
CEO of Regenera Dr. William Ardrey said “The first
indication that the clinical and medical advisory
board will address is to prove the safety and
efficacy of VisagenTM
for the visualization of the vitreous during
vitrectomy. In this procedure, VisagenTM
is used prior to surgery as a visualization aide,
and is washed out at the end of the procedure. It
acts within the eye to illuminate or delineate the
vitreous fluid.”
Dr Deupree is an ophthalmologist specializing in
diseases of the vitreous and
retina. His
sub-specialty includes medical and surgical
management of macular disorders, diabetic
retinopathy, complex
retinal detachments and trauma.
Dr Deupree is a Fellow of the American Academy of
Ophthalmology and the American College of Surgeons.
He also serves as Associate Professor at the
University of South Florida. His current research
interests include rheopheresis treatment for
macular
degeneration, in which he is a principal
investigator in the current phase III clinical
trial.
Official Regenera website
 |
|
